Exosome activation is how vesicles from mesenchymal stem cells bind target cells and switch on repair signaling such as AKT and ERK. Exosome therapy uses these cell-free vesicles, and no exosome product is FDA approved for any use.
A prolo injection for the knee (prolotherapy) is a course of dextrose injections into and around the knee joint meant to prompt tissue repair. In the 2013 Rabago trial of 90 adults with knee osteoarthritis, it improved pain, function and stiffness more than saline or home exercise at 52 weeks.
A knee stem cell procedure costs $3,000 to $25,000 or more in the U.S., depending on cell type, and no major insurer covers it for knee osteoarthritis. Results depend more on arthritis grade than on price.
An evidence-based look at stem cell therapy for hair loss, including how it works, the types available (BMAC, SVF, exosomes), clinical results, costs, and how it compares to PRP, minoxidil, and hair transplant.
Stem cell therapy for knees injects concentrated cells, usually BMAC or SVF, into an arthritic knee to ease pain. Many patients improve, but the largest trial (Nature Medicine, 2023) found it no better than a steroid shot at 12 months.
A PRP injection costs $500 to $2,500 per session for most joints, and PRP for low back pain costs about $1,000 to $3,000 per session because spinal injections need image guidance. Insurance rarely pays, but HSA and FSA funds usually can.
IV vitamin therapy is everywhere, from wellness lounges to integrative clinics. Here’s what the research actually supports, what’s marketing, and the risks you should know about.
Exosome therapy is not established as safe or effective outside clinical trials, and the FDA states that no exosome product is approved. The human evidence is limited to small trials in graft-versus-host disease, COVID-19 respiratory failure and diabetic foot ulcers.
Prolotherapy injects dextrose to trigger a controlled repair response, while PRP injects your own platelets concentrated 3 to 8 times to deliver growth factors directly. PRP has more data for tendons and knee arthritis, prolotherapy for loose ligaments, and both have mixed, cash-pay evidence.
At a Glance What it is: Stem cell therapy for back pain uses concentrated regenerative cells, most commonly bone marrow aspirate concentrate (BMAC), injected into damaged spinal structures to promote tissue repair. Conditions treated: Degenerative disc disease, facet joint osteoarthritis, and sacroiliac (SI) joint dysfunction. Evidence level: Early, small clinical trials and case series show…
Stem cell therapy for back pain injects regenerative cells into a degenerated disc or facet joint. No stem cell product is FDA approved for back pain, and small trials show benefit in some patients while larger trials are still settling the question.
Stem cell therapy for a degenerative disc typically costs $8,000 to $20,000 in the US, and a single-joint stem cell shot $5,000 to $15,000. Cell source, number of levels, imaging guidance and follow-up set the price, and insurance rarely pays.
